Literature DB >> 9409785

Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2.

D D'Orazio1, D Besser, R Marksitzer, C Kunz, D A Hume, B Kiefer, Y Nagamine.   

Abstract

We have previously shown in NIH 3T3 fibroblasts that treatment with 12-O-tetradecanoylphorbol 13-acetate (TPA) or fibroblast growth factor-2 (FGF-2) activates the Ras/Erk signaling pathway in NIH 3T3 fibroblasts, leading to the induction of the urokinase-type plasminogen activator (uPA) gene. In this study, we characterize cis-acting elements involved in this induction. DNase I hypersensitive (HS) site analysis of the uPA promoter showed that two regions were enhanced after TPA and FGF-2 treatment. One was located 2.4kb upstream of the transcription start site (-2.4kb), where a known PEA3/AP1 (AGGAAATGAGGTCAT) element is located. The other was located in a previously undefined far upstream region. Sequencing of this region revealed a similar AP1/PEA3 (GTGATTCACTTCCT) element at -6.9 kb corresponding to the HS site. Deletion analysis of the uPA promoter in transient transfection assays showed that both PEA3/AP1 elements are required for full inducibility, suggesting a synergism between the two elements. When the two sites were inserted together upstream of a minimal promoter derived from the thymidine kinase gene, expression of the reporter gene was more strongly induced by TPA and FGF-2 than with either of the two elements alone. Alone, the -6.9 element was more potent than the -2.4 element. The involvement of AP1 as well as Ets transcription factors was confirmed by examining different promoter constructs containing deletions in either the AP-1 or the PEA3 element, and by using an expression plasmid for dominant negative Ets-2. Electromobility shift analyses using specific antibodies showed that c-Jun and, JunD bind to both elements with or without induction. In addition, ATF-2 binds to the -2.4-kb element even without induction and c-Fos to the -6.9-kb element only after induction. Accordingly, overexpression of c-Fos caused induction from the -6.9-kb element, but reduced induction from the -2.4-kb element. The involvement of the Ets-2 transcription factor was shown by using expression plasmids for wild-type and dominant negative Ets-2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409785     DOI: 10.1016/s0378-1119(97)00445-9

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  21 in total

1.  Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.

Authors:  Peter C Hollenhorst; Mary W Ferris; Megan A Hull; Heejoon Chae; Sun Kim; Barbara J Graves
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

2.  Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate.

Authors:  G Cirillo; L Casalino; D Vallone; A Caracciolo; D De Cesare; P Verde
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1.

Authors:  M Koziczak; W Krek; Y Nagamine
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

4.  Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.

Authors:  David P Turner; Victoria J Findlay; Omar Moussa; Victor I Semenchenko; Patricia M Watson; Amanda C LaRue; Mohamed M Desouki; Mostafa Fraig; Dennis K Watson
Journal:  Prostate       Date:  2011-03-28       Impact factor: 4.104

5.  Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling.

Authors:  L F Fowles; M L Martin; L Nelsen; K J Stacey; D Redd; Y M Clark; Y Nagamine; M McMahon; D A Hume; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

6.  PDEF is a negative regulator of colon cancer cell growth and migration.

Authors:  Omar Moussa; David P Turner; Ron J Feldman; Victor I Sementchenko; Brent D McCarragher; Mohamed M Desouki; Mostafa Fraig; Dennis K Watson
Journal:  J Cell Biochem       Date:  2009-12-15       Impact factor: 4.429

7.  Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells.

Authors:  Gabriel M Gordon; Dolena R Ledee; William J Feuer; M Elizabeth Fini
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

8.  Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression.

Authors:  David P Turner; Victoria J Findlay; A Darby Kirven; Omar Moussa; Dennis K Watson
Journal:  Mol Biol Cell       Date:  2008-06-25       Impact factor: 4.138

9.  Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts.

Authors:  Daniel M Appledorn; Kim-Hien T Dao; Sandra O'Reilly; Veronica M Maher; J Justin McCormick
Journal:  BMC Cancer       Date:  2010-01-12       Impact factor: 4.430

10.  Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.

Authors:  Rebecca Baker; Claire V Kent; Rachel A Silbermann; John A Hassell; Lawrence J T Young; Louise R Howe
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.